XML 91 R76.htm IDEA: XBRL DOCUMENT v3.22.1
EMPLOYEE AND DIRECTOR BENEFITS - Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2007
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Company recognized cost $ 825 $ 739        
Unrecognized compensation 537 587        
Nonvested restricted stock awards 177,198 140,656 $ 126,637      
Company recorded liability 3,578 2,990        
Plan expense 589 487        
Bank owned life insurance 22,201 22,458        
Bank owned life insurance income 497 528        
Capital Surplus            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Company recognized cost 362 349        
Nonvested restricted stock awards $ 80,640 65,327 64,592      
Unvested Restricted Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Nonvested restricted stock awards   $ (439)        
Share-based Payment Arrangement, Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Incentive stock option plan (in shares) 474,336,000 1,400,000,000   975,000,000 675,000,000 450,000,000
Weighted average period of years 1 year 7 months 28 days          
Restricted Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted (in shares) 24,985,000 22,869,000        
Restricted Stock | Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period 3 years          
Restricted Stock | Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period 5 years          
Restricted Stock | Unvested Restricted Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Company recognized cost $ 463 $ 390        
Nonvested restricted stock awards $ (477)   $ (392)